Entrada Therapeutics Inc
NASDAQ:TRDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Entrada Therapeutics Inc
NASDAQ:TRDA
|
US |
|
Vita Coco Company Inc
NASDAQ:COCO
|
US |
|
Bank Mayapada Internasional Tbk PT
IDX:MAYA
|
ID |
|
Ecomiam SA
PAR:ALECO
|
FR |
|
Roda Vivatex Tbk PT
IDX:RDTX
|
ID |
|
Giglio Group SpA
MIL:GG
|
IT |
|
D
|
Dongkuk Structures & Construction Co Ltd
KOSDAQ:100130
|
KR |
|
S
|
Smart Powerr Corp
F:CR9
|
CN |
|
Vivakor Inc
NASDAQ:VIVK
|
US |
|
S
|
Stericycle Inc
DUS:SY9
|
US |
|
Ambac Financial Group Inc
NYSE:AMBC
|
US |
|
T
|
Temapol Polimer Plastik ve Insaat Sanayi Ticaret AS
IST:TMPOL.E
|
TR |
|
S
|
SD Biotechnologies Co Ltd
KOSDAQ:217480
|
KR |
|
TotalEnergies SE
PAR:TTE
|
FR |
|
Pointerra Ltd
OTC:PTRRF
|
AU |
|
A
|
Amazon.com Inc
BMV:AMZN
|
US |
|
W
|
Whitbread PLC
XMUN:WHF4
|
UK |
|
FlexShopper Inc
NASDAQ:FPAY
|
US |
|
L
|
Lancer Container Lines Ltd
NSE:LANCER
|
IN |
|
ManpowerGroup Inc
NYSE:MAN
|
US |
|
Anfield Energy Inc
NASDAQ:AEC
|
CA |
Bankruptcy Probability
Entrada Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Entrada Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Entrada Therapeutics Inc
NASDAQ:TRDA
|
279.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
459.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
240.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
87.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
55.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Entrada Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Entrada Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
